Cargando…
Fenretinide: A Novel Treatment for Endometrial Cancer
Resistance to progestin treatment is a major hurdle in the treatment of advanced and reoccurring endometrial cancer. Fenretinide is a synthetic retinoid that has been evaluated in clinical trials as a cancer therapeutic and chemo-preventive agent. Fenretinide has been established to be cytotoxic to...
Autores principales: | Mittal, Navdha, Malpani, Saurabh, Dyson, Matthew, Ono, Masanori, Coon, John S., Kim, Julie J., Schink, Julian C., Bulun, Serdar E., Pavone, Mary Ellen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207704/ https://www.ncbi.nlm.nih.gov/pubmed/25340777 http://dx.doi.org/10.1371/journal.pone.0110410 |
Ejemplares similares
-
Generation of Progesterone-Responsive Endometrial Stromal Fibroblasts from Human Induced Pluripotent Stem Cells: Role of the WNT/CTNNB1 Pathway
por: Miyazaki, Kaoru, et al.
Publicado: (2018) -
Genome-Wide DNA Methylation Analysis Predicts an Epigenetic Switch for GATA Factor Expression in Endometriosis
por: Dyson, Matthew T., et al.
Publicado: (2014) -
Role of Stem Cells in Human Uterine Leiomyoma Growth
por: Ono, Masanori, et al.
Publicado: (2012) -
Fenretinide Causes Emphysema, Which Is Prevented by Sphingosine 1-Phoshate
por: Yasuo, Masanori, et al.
Publicado: (2013) -
Fenretinide Acts as Potent Radiosensitizer for Treatment of Rhabdomyosarcoma Cells
por: Brack, Eva, et al.
Publicado: (2021)